AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like QuintilesIMS Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance February 13, 2017 Siemens to Replace Healthineers CFO in Preparation for Listing November 8, 2017 4 Hot Biotech Stocks in 2017 July 30, 2017
QuintilesIMS Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance February 13, 2017
